H.R. 1249House110th Congress (2007-2009)In Committee

To include dehydroepiandrosterone as an anabolic steroid.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

3 earlier actions

HouseCommittee Latest Action

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Crime and Federal Government Surveillance Subcommittee

March 19, 2007

View full timeline

HouseIntro Referral

Introduced in House

February 28, 2007

HouseIntro Referral

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Energy and Commerce Committee

February 28, 2007

HouseCommittee

Referred to the Subcommittee on Health.

Health Subcommittee

March 1, 2007

HouseCommittee

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Crime and Federal Government Surveillance Subcommittee

March 19, 2007

Bill Text

Latest available legislative text

Reading Mode

Raw Text PDF XML

Introduced in HouseIssued February 28, 2007

110th CONGRESS

1st Session

H. R. 1249

IN THE HOUSE OF REPRESENTATIVES

February 28, 2007

Mr. Roskam introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To include dehydroepiandrosterone as an anabolic steroid.

Inclusion of dehydroepiandrosterone

Section 102(41)(A) of the Controlled Substances Act (21 U.S.C. 802(41)(A)) is amended—

(1)

in the matter preceding clause (i), by striking corticosteroids, and dehydroepiandrosterone and inserting and corticosteroids;

(2)

by redesignating clauses (x) through (xlx) as clauses (xi) through (xlxi), respectively; and

(3)

by inserting after clause (ix) the following:

(x)

dehydroepiandrosterone (androst-5-en-3β-ol-17-one);